One of the biggest diseases of the modern era is a pernicious cluster of risk factors called metabolic syndrome, and Northwestern scientists across disciplines are looking for new ways to understand, target, treat, and even prevent this syndrome, with the hopes of ultimately creating a much healthier nation.
Northwestern Medicine scientists and clinicians have continued to investigate methods to combat the disease, including strategies to conduct clinical trials during a pandemic, studying neurologic symptoms in children and reflecting on the importance of professional medical organizations during a public health crisis.
A Northwestern Medicine study has shown that a high-intensity home-based walking exercise program improved walking ability in people with peripheral artery disease.
The AXL immune cell receptor has been linked to cardiac allograft vasculopathy, a thickening of vessel walls in transplanted hearts years after implantation, according to a recent study.
A team of Northwestern Medicine investigators have identified specific genetic regions that regulate the expression of genes associated with inherited cardiomyopathy and disease severity.
Inhibiting an inflammatory pathway reduced heart attack-induced damage in experimental models, according to a recent Northwestern Medicine study.
A mother’s heart health while she is pregnant may have a significant impact on her child’s cardiovascular health in early adolescence, according to a new study from Northwestern and Lurie Children’s Hospital.
Northwestern Medicine investigators have discovered a potential multi-faceted therapeutic target for preventing and treating the metabolic syndrome, according to a recent study.
A new class of drugs shows benefit for both cardiovascular and kidney conditions, but scientists should be cautious in designing trials that include both cardiovascular and kidney outcomes in the same analysis, according to a Northwestern Medicine review article.